Authors
Loading...
Randomized trial reveals no significant risk of pancreatitis or biliary disease in adults with type 2 diabetes and low CV risk, suggesting treatment safety.
PAIK et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: